跳至主要内容
临床试验/NCT01631682
NCT01631682已完成4 期

Psychophysiology of Delayed Extinction and Reconsolidation in Humans

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 186 人开始时间: 2010年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
186
试验地点
1
主要终点
Change From Baseline Skin Conductance Response

研究概览

简要总结

The aim of this project is to create fear conditioning paradigm within which the relative strengths of various novel pharmacological and behavioral interventions can be tested. These interventions are intended to reduce the fearfulness associated with fear conditioning by blocking a memory process known as reconsolidation. In fear conditioning, a "conditioned" stimulus (CS) is paired with an aversive "unconditioned" stimulus (US) such as an electric shock, until presentation of the CS alone comes to elicit a fear conditioned response (CR). The investigators hypothesize that by using a more highly prepared CS (i.e. video of spiders); more sensitive subjects (individuals with stronger acquired CRs); and additional experimental probes for the presence of the latent CR, the investigators may develop a normal human paradigm that is not plagued by previously observed floor effects (i.e. intervention is 100% effective), within which both the established techniques of propranolol and delayed extinction will produce significant, but only partial, CR reduction. This would leave room to test and compare potentially more powerful candidate reconsolidation-blocking or memory-updating interventions. To achieve these aims, subjects will undergo a four-day fear conditioning and delayed extinction protocol. Skin conductance response data will be gathered across the different phases of the experiment.

详细描述

  1. BACKGROUND AND SIGNIFICANCE 1.1. Reconsolidation and its modification. Recent animal research suggests that reactivation (retrieval) of a consolidated memory can return it to a labile state from which it must be restabilized in order to persist. This stabilization process has been termed "reconsolidation," and various behavioral and pharmacologic interventions have been found to modify or block it. Although extinction can reduce or even apparently eliminate conditioned fear, it typically does so by inhibiting the expression of the fear memory, not by erasing it. In contrast, blockade of reconsolidation is believed to erase, or at least diminish, the fear memory trace. It is not uncommon for reconsolidation articles to conclude with a statement that this offers novel therapeutic possibilities for PTSD, which may in part be characterized as a disorder of over-consolidated, persistently disturbing memories that do not go away.1
  2. SPECIFIC AIM The aim of this project is to create an experimental assay in the form of an optimal Pavlovian differential fear conditioning paradigm, within which the relative strengths of various novel pharmacological and behavioral, reconsolidation-blocking interventions can be tested. As impressive as the Kindt8 and Schiller10 studies are for demonstrating pharmacological and behavioral fear reconsolidation-blocking interventions in normal humans, the results produced by these interventions make them nearly useless as potential assays for reconsolidation blockade. Specifically, both interventions produced an apparent total abolition of the fear memory, i.e., they both contain a floor effect. The aim in this work is to develop a normal human paradigm within which both propranolol and delayed extinction produce significant, but only partial reduction of the CR, which might then be improved upon by more powerful reconsolidation-blocking interventions. This study will not be used to support a label, advertising, or indication change of propanolol, and will not be prescribed in a patient population, route of administration, or dosage that significantly increases risk.

2.1. Elements of a new design to eliminate the floor effect 2.1.1. A stronger US. One way to produce a CR that is more resistant to reconsolidation blockade, i.e., to reduce the floor effect, would be to use a stronger US. However, because in our ongoing human conditioning studies, we are already using an electric shock selected in advance by subjects to be "highly annoying but not painful," we believe that to use a level of shock above this would be ethically impermissible, and hence we will not pursue this possibility.

2.1.2. A more highly "prepared" CS. It has long been shown that certain classes of CSs, when paired with a US, produce a stronger fear CR, i.e., they are more "prepared" to enter into an association with the US.13 The Schiller design10 did not use a prepared CS, but the Kindt study8 did, viz., still pictures of spiders. In our design, we will enhance the preparedness of the CS by using 12-sec.14 high-definition video clips of three different crawling tarantulas, each conspicuously different in appearance. Importantly, however, the present project will not be a study of spider fear or phobia; we will only use high-definition videoto enhance CS preparedness.

2.1.3. More sensitive subjects. We will limit recruitment to subject candidates who fall within the upper half of the distribution of normal humans on the Spider Phobia Questionnaire-1515 (SPQ-15) and for whom the CSs are likely to be especially salient. However in order to avoid potential adverse clinical consequences of participation, we will exclude subjects with features of diagnosable spider phobia (or the presence of any other Axis I mental disorder).

2.1.4. Selecting subjects with stronger CRs. In order for a subject who has completed the Day 1 Acquisition phase of the experiment to proceed to the remaining phases, we will require that they show strong evidence of conditioning, as manifest in CRs greater than 0.25 µSiemens to at least two CS+s. The Schiller study10 employed a differential conditioning cut-off of 0.10 µSiemens, but based upon our own experience, we favor the raw score cut-off. The Kindt study8 employed no such cut-off.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-35
  • Top half of the normal human distribution of the Spider Phobia Questionnaire-15

排除标准

  • Any criteria for diagnosable spider phobia
  • Any current Axis I mental disorder on the Structured Clinical Interview for DSM-IV (SCID)
  • Presence of drugs of abuse (e.g. opiates, marijuana, cocaine, or amphetamines) per urine screen
  • Non-English speaking (due to lack of validated questionnaires/instruments in other languages)

研究组 & 干预措施

Propranolol

Active Comparator

a single dose of 40mg propranolol may be given to begin visit 2, followed by 90min wait and subsequently CS reactivation

干预措施: Propranolol (Drug)

Reactivation with time delay

Active Comparator

For those not receiving propranolol on visit 2, one experimental CS will be reactivated, followed by a 10 minute break and subsequently extinction

干预措施: Reactivation (Behavioral)

Mifepristone

Experimental

a single dose of 1800mg (200mg tablets) mifepristone may be given to begin visit 2, followed by 90min wait and subsequently CS reactivation

干预措施: Mifepristone (Drug)

Intranasal oxytocin

Experimental

A single 32IU dose of Syntocinon (intranasal oxytocin) is given to begin visit 2, followed by a 10 minute wait and subsequent CS reactivation.

干预措施: Intranasal oxytocin (Drug)

结局指标

主要结局

Change From Baseline Skin Conductance Response

时间窗: 48hrs

Skin conductance response (SCR) is the change in skin conductance level in response to a stimulus. We compared the SCR to a non-treated conditioned stimulus (CS+N) with the SCR to a treated conditioned stimulus (CS+R) by creating a difference score (CS+R - CS+N) for the day 3 data. Day 3 is 48 hours after the fear-conditioning procedure and serves as the primary measure of whether the treatment had an effect. SCR was measured in microSiemens; the SCR difference score reflects a change in microSiemens.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Scott Orr

Associate Professor of Psychology

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验